WallStreetZenWallStreetZen

NASDAQ: MYMD
Mymd Pharmaceuticals Inc Stock Ownership - Who owns Mymd Pharmaceuticals?

Insider buying vs selling

Have Mymd Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Paul RivardChief Legal Officer2023-08-24150,000$1.11
$166.50kBuy
Paul RivardChief Legal Officer2023-08-1725,000$1.12
$28.08kBuy

1 of 1

MYMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MYMD insiders and whales buy or sell their stock.

MYMD Shareholders

What type of owners hold Mymd Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Caroline C. Williams232.54%5,017,423$14.10MInsider
Mirae Asset Global Investments Co Ltd144.07%3,108,473$8.73MInstitution
Vanguard Group Inc67.59%1,458,295$4.10MInstitution
Thomas J. Knox22.16%478,150$1.34MInsider
Paul Rivard18.54%400,000$1.12MInsider
Geode Capital Management LLC13.50%291,229$818.35kInstitution
Hudson Bay Capital Management LP11.14%240,305$675.26kInsider
Raymond Francis Akers Jr.9.83%212,100$596.00kInsider
Blackrock Inc9.55%206,078$579.08kInstitution
Praetorian Wealth Management Inc9.27%200,000$562.00kInstitution

1 of 3

MYMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MYMD46.54%53.46%Net Buying
IBIO0.72%99.28%Net Selling
PCSA23.32%76.68%Net BuyingNet Buying
PTIX2.55%1.03%Net Buying
SCPX4.71%17.31%

Mymd Pharmaceuticals Stock Ownership FAQ

Who owns Mymd Pharmaceuticals?

Mymd Pharmaceuticals (NASDAQ: MYMD) is owned by 294.13% institutional shareholders, 337.81% Mymd Pharmaceuticals insiders, and 0.00% retail investors. Caroline C. Williams is the largest individual Mymd Pharmaceuticals shareholder, owning 5.02M shares representing 232.54% of the company. Caroline C. Williams's Mymd Pharmaceuticals shares are currently valued at $14.25M.

If you're new to stock investing, here's how to buy Mymd Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.